Cartilage-derived morphogenetic protein-1 and cartilage-derived morphogenetic protein-2 are present in ligament fibroblasts and lead to chondrogenic differentiation

por Bobacz, K, Erlacher, L, Smolen, J, Graninger, W
Publicado 2003

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis

por Hayer, Silvia, Niederreiter, B, Smolen, J, Redlich, K
Publicado 2012

Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition

por Schoels, M., Alasti, F., Smolen, J. S., Aletaha, D.
Publicado 2017

Chondrocyte number and proteoglycan synthesis in the ageing and osteoarthritic human articular cartilage

por Bobacz, K, Soleiman, A, Erlacher, L, Smolen, J, Graninger, WB
Publicado 2003

Direct analysis of bone turnover in experimental arthritis

por Polzer, K, Tuerk, B, Redlich, K, Hayer, S, Smolen, J, Schett, G
Publicado 2005

Autoantibodies in very early rheumatoid arthritis: diagnostic tools or pathogenic players?

por Steiner, G, Nell, V, Eberl, G, Hayer, S, Machold, K, Hoefler, E, Smolen, J
Publicado 2003

Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue

por Hayer, S, Tohidast-Akrad, M, Schett, G, El Gabalawy, H, Smolen, J, Steiner, G
Publicado 2002

Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice

por Redlich, K, Goertz, B, Doerr, N, Kollias, G, Steiner, G, Smolen, J, Schett, G
Publicado 2003

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice

por Schett, G, Hayer, S, Xu, Q, Tohidast-Akrad, M, Kollias, G, Steiner, G, Smolen, J
Publicado 2001

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)

por Aringer, M, Steiner, G, Graninger, WB, Höfler, E, Hiesberger, H, Steiner, C-W, Smolen, J
Publicado 2003

Treating rheumatoid arthritis to target: the patient version of the international recommendations

por de Wit, M P T, Smolen, J S, Gossec, L, van der Heijde, D M F M
Publicado 2011

The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis

por Nell, V, Machold, K, Hueber, W, Eberl, G, Hiesberger, H, Hoefler, E, Smolen, J, Steiner, G
Publicado 2003

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features

por Schett, G, Monneaux, F, Hoefler, E, Fritsch, R, Tohidast-Akrad, M, Smolen, J, Muller, S, Steiner, G
Publicado 2003

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma

por Jimenez-Boj, E, Schett, G, Kedersha, N, Zimmermann, C, Hoefler, E, Smolen, J, Anderson, P, Steiner, G
Publicado 2002

Aberrant expression of the autoantigen hnRNP-A2/RA33 in the joints of patients with rheumatoid arthritis and TNF-alpha transgenic mice: a clue to autoimmunity?

por Hayer, S, Tohidast-Akrad, M, Schett, G, Skriner, K, Plows, D, Haralambos, S, Kollias, G, Smolen, J, Steiner, G
Publicado 2001

Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients

por Fritsch, R, Eselböck, D, Jahn-Schmid, B, Neumueller, J, Bohle, B, Skriner, K, Smolen, J, Steiner, G
Publicado 2001

Clinical joint inactivity predicts structural stability in patients with established rheumatoid arthritis

por Gärtner, M, Sigmund, I K, Alasti, F, Supp, G, Radner, H, Machold, K, Smolen, J S, Aletaha, D
Publicado 2016

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction

por Zwerina, J, Hayer, S, Redlich, K, Feige, U, Dunstan, C, Bergmeister, H, Kollias, G, Steiner, G, Smolen, J, Schett, G
Publicado 2003

Characterization of autoreactive T cells to the autoantigens hnRNP-A2/RA33 and filaggrin in patients with rheumatoid arthritis and controls

por Fritsch, R, Eselböck, D, Jahn-Schmid, B, Scheinecker, C, Bohle, B, Skriner, K, Neumüller, J, Smolen, J, Steiner, G
Publicado 2001

Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data

por Dougados, M, Schmidely, N, Le Bars, M, Lafosse, C, Schiff, M, Smolen, J S, Aletaha, D, van Riel, P, Wells, G
Publicado 2008